Expression analysis of the ligands for the natural killer cell receptors NKp30 and NKp44

PLoS ONE

Volumn 2, Issue 12, 2007, Pages

  Byrd, Andreina ^a   Hoffman, Sabrina C ^a   Jarahian, Mostafa ^b   Momburg, Frank ^b   Watzl, Carsten ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKP30; NATURAL KILLER CELL RECEPTOR NKP44; TRYPSIN; IMMUNOGLOBULIN RECEPTOR; LIGAND; NCR2 PROTEIN, HUMAN; NCR3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL TRANSFORMATION; CONTROLLED STUDY; CORRELATION FUNCTION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SENSITIVITY ANALYSIS; TUMOR CELL DESTRUCTION; TUMOR CELL LINE; CELL LINE; GENETICS; METABOLISM; NATURAL KILLER CELL;

CELL LINE, TRANSFORMED; HUMANS; KILLER CELLS, NATURAL; LIGANDS; RECEPTORS, IMMUNOLOGIC;

EID: 44349162188     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001339     Document Type: Article

References (39)

1. Zamai L, Ponti C, Mirandola P, Gobbi G, Papa S, et al. (2007) NK cells and cancer. J Immunol 178: 4011-4016.
2. Lee SH, Miyagi T, Biron CA (2007) Keeping NK cells in highly regulated antiviral warfare. Trends Immunol 28: 252-259.
3. Arnon TI, Markel G, Mandelboim O (2006) Tumor and viral recognition by natural killer cells receptors. Semin Cancer Biol 16: 348-358.
4. Ljunggren HG, Malmberg KJ (2007) Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol 7: 329-339.
5. Hayakawa Y, Smyth MJ (2006) Innate immune recognition and suppression of tumors. Adv Cancer Res 95: 293-322.
6. Wu J, Lanier LL (2003) Natural killer cells and cancer. Adv Cancer Res 90: 127-156.
7. Ruggeri L, Mancusi A, Burchielli E, Aversa F, Martelli MF, et al. (2007) Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. Curr Opin Oncol 19: 142-147.
8. Bhat R, Eissmann P, Endt J, Hoffmann S, Watzl C (2006) Fine-tuning of immune responses by SLAM-related receptors. J Leukoc Biol 79: 417-424.
9. Moretta L, Moretta A (2004) Unravelling natural killer cell function: triggering and inhibitory human NK receptors. Embo J 23: 255-259.
10. Newman KC, Riley EM (2007) Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat Rev Immunol 7: 279-291.
11. Moretta L, Moretta A (2004) Killer immunoglobulin-like receptors. Curr Opin Immunol 16: 626-633.
12. Kumar V, McNerney ME (2005) A new self: MHC-class-I-independent natural-killer- cell self-tolerance. Nat Rev Immunol 5: 363-374.
13. Lanier LL (2005) NK cell recognition. Annu Rev Immunol 23: 225-274.
14. Pende D, Parolini S, Pessino A, Sivori S, Augugliaro R, et al. (1999) Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med 190: 1505-1516.
15. Pessino A, Sivori S, Bottino C, Malaspina A, Morelli L, et al. (1998) Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med 188: 953-960.
16. Vitale M, Bottino C, Sivori S, Sanseverino L, Castriconi R, et al. (1998) NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med 187: 2065-2072.
17. Sivori S, Pende D, Bottino C, Marcenaro E, Pessino A, et al. (1999) NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur J Immunol 29: 1656-1666.
18. Nolte-'t Hoen EN, Almeida CR, Cohen NR, Nedvetzki S, Yarwood H, et al. (2007) Increased surveillance of cells in mitosis by human NK cells suggests a novel strategy for limiting tumor growth and viral replication. Blood 109: 670-673.
19. Moretta L, Ferlazzo G, Bottino C, Vitale M, Pende D, et al. (2006) Effector and regulatory events during natural killer-dendritic cell interactions. Immunol Rev 214: 219-228.
20. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, et al. (2001) Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409: 1055-1060.
21. Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, et al. (2001) Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol 31: 2680-2689.
22. Arnon TI, Achdout H, Levi O, Markel G, Saleh N, et al. (2005) Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol 6: 515-523.
23. Mavoungou E, Held J, Mewono L, Kremsner PG (2007) A Duffy binding-like domain is involved in the NKp30-mediated recognition of Plasmodium falciparum-parasitized erythrocytes by natural killer cells. J Infect Dis 195: 1521-1531.
24. Chisholm SE, Howard K, Gomez MV, Reyburn HT (2007) Expression of ICP0 is sufficient to trigger natural killer cell recognition of herpes simplex virus-infected cells by natural cytotoxicity receptors. J Infect Dis 195: 1160-1168.
25. Chisholm SE, Reyburn HT (2006) Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors. J Virol 80: 2225-2233.
26. Vieillard V, Strominger JL, Debre P (2005) NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand. Proc Natl Acad Sci U S A 102: 10981-10986.
27. Bloushtain N, Qimron U, Bar-Ilan A, Hershkovitz O, Gazit R, et al. (2004) Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46. J Immunol 173: 2392-2401.
28. Hershkovitz O, Jivov S, Bloushtain N, Zilka A, Landau G, et al. (2007) Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44. Biochemistry 46: 7426-7436.
29. Warren HS, Jones AL, Freeman C, Bettadapura J, Parish CR (2005) Evidence that the cellular ligand for the human NK cell activation receptor NKp30 is not a heparan sulfate glycosaminoglycan. J Immunol 175: 207-212.
30. Arnon TI, Achdout H, Lieberman N, Gazit R, Gonen-Gross T, et al. (2004) The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 103: 664-672.
31. Nowbakht P, Ionescu MC, Rohner A, Kalberer CP, Rossy E, et al. (2005) Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias. Blood 105: 3615-3622.
32. Stark S, Flaig RM, Sandusky M, Watzl C (2005) The use of trimeric isoleucinezipper fusion proteins to study surface-receptor-ligand interactions in natural killer cells. J Immunol Methods 296: 149-158.
33. Costello RT, Sivori S, Marcenaro E, Lafage-Pochitaloff M, Mozziconacci MJ, et al. (2002) Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 99: 3661-3667.
34. Bryceson YT, March ME, Ljunggren HG, Long EO (2006) Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107: 159-166.
35. Sivori S, Parolini S, Falco M, Marcenaro E, Biassoni R, et al. (2000) 2B4 functions as a co-receptor in human NK cell activation. Eur J Immunol 30: 787-793.
36. Bottino C, Falco M, Parolini S, Marcenaro E, Augugliaro R, et al. (2001) NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J Exp Med 194: 235-246.
37. Watzl C, Long EO (2003) Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts. J Exp Med 197: 77-85.
38. Jarahian M, Watzl C, Issa Y, Altevogt P, Momburg F (2007) Blockade of natural killer cell-mediated lysis by NCAM140 expressed on tumor cells. Int J Cancer 120: 2625-2634.
39. Messmer B, Eissmann P, Stark S, Watzl C (2006) CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells. J Immunol 176: 4646-465